TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 122 filers reported holding TCR2 THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 2.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $77,892 | -48.1% | 9,153 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $150,201 | -14.5% | 9,153 | +15.0% | 0.00% | -33.3% |
| Q1 2021 | $175,713 | -28.6% | 7,958 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $246,141 | +52.2% | 7,958 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $161,707 | +85.7% | 7,958 | +40.4% | 0.00% | +50.0% |
| Q2 2020 | $87,091 | – | 5,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 3,370,982 | $68,498,000 | 16.50% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $82,314,000 | 15.35% |
| Consonance Capital Management LP | 1,509,819 | $30,680,000 | 3.74% |
| Soleus Capital Management, L.P. | 282,041 | $5,731,000 | 3.04% |
| Redmile Group, LLC | 2,793,288 | $56,760,000 | 1.04% |
| PFM Health Sciences, LP | 775,794 | $15,764,000 | 0.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,200,000 | $24,384,000 | 0.59% |
| Cormorant Asset Management, LP | 600,000 | $12,192,000 | 0.47% |
| Sofinnova Investments, Inc. | 173,028 | $3,516,000 | 0.26% |
| Artal Group S.A. | 500,000 | $10,160,000 | 0.25% |